Open AccessRegulation of p21, MMP-1, and MDR-1 Expression in Human Colon Carcinoma HT29 Cells by Tian Xian Liquid, a Chinese Medicinal Formula, In Vitro and In Vivo
Author(s) -
Stephen Cho Wing Sze,
Ka-Lok Wong,
Wing K Liu,
Tzi Bun Ng,
Jack Ho Wong,
Ho Cheung,
Christine M.L. Yow,
Ellie S.M. Chu,
Qing Liu,
Yong Hu,
Kenneth W. Tsang,
Wai S. Lee,
Yao Tong
Publication year - 2010
Publication title -
integrative cancer therapies
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 60
eISSN - 1552-695X
pISSN - 1534-7354
DOI - 10.1177/1534735410378743
Subject(s) - cell cycle , cell growth , flow cytometry , in vivo , multiple drug resistance , medicine , cancer research , pharmacology , cancer , chemistry , biology , drug resistance , immunology , biochemistry , microbiology and biotechnology
Tian-Xian liquid (TXL), a commercially available Chinese medicine decoction, has been used as an anticancer dietary agent for more than 10 years without reported side effects.